Inflammatory mediators found in the CF airways such as TNF-α, IL-1β, and IL-17 have been shown to augment CFTR modulator efficacy in cultured cells (54, 55) and their higher baseline levels correlate with improved ppFEV1 after ivacaftor (54). The gene discussed is IL17A; the disease is cystic fibrosis.